Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-10-08 Capital/Financing Update
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera S.p.A. - Rinegoziato il termine di rimborso della debenture note 2018-21; Dismissione di partecipazioni e opere d’arte di proprietà.
Capital/Financing Update Classification · 1% confidence The document is an official communication from Bioera S.p.A. dated October 8, 2021, identified by the header "Informazione Regolamentata n. 0771-77-2021" and filed on the MTA market. The subject matter concerns the renegotiation of a debt repayment deadline ('Rinegoziato il termine di rimborso della debenture note 2018-21') and the planned divestment of assets ('Dismissione di partecipazioni e opere d'arte di proprietà'). This type of announcement, detailing significant financial restructuring, debt management, and asset sales outside of standard periodic reporting (like 10-K or IR), fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were less specific. Since it directly addresses changes to capital structure (debt renegotiation and asset sales to generate liquidity for repayment), 'CAP' is the most precise fit. It is not a full report (10-K, IR), an earnings release (ER), or a management discussion (MDA), but a specific corporate action announcement.
2021-10-08 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Capital/Financing Update Classification · 1% confidence The document is an official regulatory announcement (indicated by the structured header with 'Informazione Regolamentata' and 'MTA') dated September 30, 2021. The subject ('Oggetto') is 'Bioera S.p.A. - Richiesta di conversione Warrant A' (Request for conversion of Warrant A). The text details the conversion of warrants into new ordinary shares, specifying the number of warrants converted, the resulting share count, and the exercise price. This action directly relates to changes in the company's capital structure and financing instruments. This fits the definition of 'Capital/Financing Update' (CAP) better than a general regulatory filing (RNS) because it concerns a specific financing event (warrant conversion leading to share issuance). It is not an earnings release, an annual report, or a management discussion, but a specific corporate action related to capital.
2021-09-30 Italian
Bioera S.p.A. - Relazione Finanziaria Semestrale al 30 giugno 2021
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bilancio consolidato semestrale abbreviato' (Condensed Consolidated Half-Year Financial Report) for Bioera S.p.A. as of June 30, 2021. It contains detailed financial statements (income statement, balance sheet, net financial position), management's discussion and analysis (Relazione degli Amministratori sulla gestione), and market analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2021
2021-09-30 Italian
Bioera S.p.A. - Relazione della società di revisione RSM al bilancio consolidato al 30.06.2021 e pubblicazione della Relazione Finanziaria Semestrale
Audit Report / Information Classification · 1% confidence The document is an official communication from Bioera S.p.A. dated September 30, 2021, regarding the publication of its 'Relazione Finanziaria Semestrale 2021' (Semi-Annual Financial Report for the period ended June 30, 2021). Crucially, the document explicitly includes the full text of the 'Relazione della società di revisione RSM S.p.A. al bilancio consolidato semestrale abbreviato' (Auditor's Report on the condensed half-yearly consolidated financial statements). This report details the auditor's inability to express an opinion on the financial statements due to significant issues (going concern, deconsolidation of Ki Group S.r.l., etc.). Since the document contains the comprehensive auditor's report accompanying a periodic financial statement (half-yearly), it strongly aligns with the definition of an Audit Report/Information (AR). While it announces the publication of the Interim Report (IR), the core content provided is the auditor's findings on that report, making AR the most specific fit among the financial reporting categories, as it is not the full Annual Report (10-K) or just a brief announcement (RPA/RNS). H1 2021
2021-09-30 Italian
Bioera S.p.A. - Informativa al mercato ex art. 114, co. 5, D.lgs. n. 58/98 (“TUF”) - periodo di riferimento: 31.08.2021
Capital/Financing Update Classification · 1% confidence The document is an official communication titled "Informativa al mercato ai sensi dell'art. 114, comma 5, D.lgs. n. 58/98 ('TUF')" from Bioera S.p.A., dated September 29, 2021, referencing data as of August 31, 2021. This specific Italian regulation (TUF Article 114, paragraph 5) mandates the disclosure of net financial debt periodically. This type of periodic financial disclosure, which is comprehensive for a specific reference date but not a full annual report (10-K) or a standard quarterly earnings release (ER), aligns best with the definition of an Interim/Quarterly Report (IR), as it provides detailed financial metrics (net debt calculation) for a period shorter than a year (reference date 31.08.2021). Although it is a regulatory filing, 'IR' is more specific than the general 'RNS' or 'LTR' categories for this type of financial update.
2021-09-29 Italian
Bioera S.p.A. - Comunicazione di variazione del capitale sociale
Share Issue/Capital Change Classification · 1% confidence The document is an official communication ('Informazione Regolamentata') from Bioera S.p.A. dated September 22, 2021. The subject ('Oggetto') is 'Bioera S.p.A. - Comunicazione di variazione del capitale sociale' (Communication of change in share capital). The text details the new composition of the share capital following the conversion of warrants and provides a table comparing the previous and current share counts and capital amounts. This directly relates to changes in the company's capital structure. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it involves share changes, it is a formal notification of the resulting capital structure change rather than a simple buyback announcement (POS) or a general share issue announcement (SHA), making CAP the most precise fit for a formal capital structure update following financing/conversion events.
2021-09-22 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.